Security key
05338F306
Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)
CUSIP: 05338F306
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 8,255,057
- Total 13F value
- $66,123,710
- Share change
- +724,536
- SEC-reported price per share
- $8.01
- Number of holders
- 33
- Value change
- +$5,779,142
- Number of buys
- 15
- Number of sells
- 8
- Shares outstanding
- 53,624,847
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
33
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05338F306
Recent filing periods:
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
31 Dec 2024
3/4/5
13F
Highest disclosed value: $7,702,525
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL has the largest disclosed position value at $7.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$397.8K
BVF INC/IL
$7.7M
Ikarian Capital, LLC
$7.21M
ORBIMED ADVISORS LLC
$7.18M
RA CAPITAL MANAGEMENT, L.P.
$7.18M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$397,771
765,828 shares
|
— | 26 Jun 2023 |
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$7,702,525
1,036,679 shares
|
— | 31 Dec 2024 |
| Ikarian Capital, LLC |
13F
Company
|
—
denominator unverified
|
$7,209,024
970,259 shares
|
— | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$7,184,810
967,000 shares
|
— | 31 Dec 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
—
denominator unverified
|
$7,184,810
967,000 shares
|
— | 31 Dec 2024 |
| Deep Track Capital, LP |
13F
Company
|
—
denominator unverified
|
$6,441,810
867,000 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
8,255,057
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
33
Q1 2025 holders
33
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend